Last reviewed · How we verify
A51R1 Tab. and A51R2 Tab.
At a glance
| Generic name | A51R1 Tab. and A51R2 Tab. |
|---|---|
| Also known as | Reference drug |
| Sponsor | AJU Pharm Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults (PHASE1)
- The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- A51R1 Tab. and A51R2 Tab. CI brief — competitive landscape report
- A51R1 Tab. and A51R2 Tab. updates RSS · CI watch RSS
- AJU Pharm Co., Ltd. portfolio CI